Terrestrial Bio, Inc. filed a Form D with the Securities and Exchange Commission on 2026-03-19.
Terrestrial Bio, Inc. filed a Form D notice of an exempt securities offering with the SEC on March 19, 2026. Terrestrial Bio, Inc. was formerly named Vaxess Technologies, Inc. The filing reports $57.30M sold. Its industry group is Biotechnology. It names Rachel Sha (Executive Officer, Director), Kathryn Kousda (Executive Officer, Director), Ann DeWitt (Director) (SEC Form D, March 19, 2026).
In its own words: “Terrestrial is transforming the delivery of next-generation therapies, starting with GLP-1.” (terrestrialbio.com, checked November 1, 2026)
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Is this your company?
Sell to companies like Terrestrial Bio, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-03-19 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Terrestrial Bio, Inc.
Free to see. No signup.
More on the people and the money behind Terrestrial Bio, Inc., from the filings we hold.
Biotechnology raises by companies based in Massachusetts, filed in March 2026, largest first.
Get an email when Terrestrial Bio, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Terrestrial Bio, Inc. raises, hires or launches. No email unless you switch it on.
Watch Terrestrial Bio, Inc. →Get the full cited report on Terrestrial Bio, Inc.
What the filing shows about Terrestrial Bio, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Terrestrial Bio, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Terrestrial Bio, Inc.'s address as 30 Cummings Park Drive, Woburn, MA 01801.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Terrestrial Bio, Inc. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Terrestrial Bio, Inc. is a registered filer with the SEC (CIK 1578117) and has filed since 2022-10-04. 6 filings are on record, the latest on 2026-03-19.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Terrestrial Bio, Inc.'s Form D of 2026-03-19 names Rachel Sha, Kathryn Kousda, Ann DeWitt and 4 more as its officers, directors or promoters.
Its new offerings report $95.48M sold across 6 offerings, as its own filings state.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 771 filings in Biotechnology, totalled by week. The dot is this raise, $57.30M, on the same scale — one filing against the whole group's total, so it sits low by construction.
Rachel Sha is named as Executive Officer and Director on the Form D that Terrestrial Bio, Inc. filed with the SEC on 19 March 2026, one of 7 people that filing names.
Kathryn Kousda is named as Executive Officer and Director on the Form D that Terrestrial Bio, Inc. filed with the SEC on 19 March 2026, one of 7 people that filing names.
Ann DeWitt is named as Director on the Form D that Terrestrial Bio, Inc. filed with the SEC on 19 March 2026, one of 7 people that filing names.
Livio Valenti is named as Executive Officer on the Form D that Terrestrial Bio, Inc. filed with the SEC on 19 March 2026, one of 7 people that filing names.
Peter Kolchinsky is named as Director on the Form D that Terrestrial Bio, Inc. filed with the SEC on 19 March 2026, one of 7 people that filing names.
Fenel Eloi is named as Director on the Form D that Terrestrial Bio, Inc. filed with the SEC on 19 March 2026, one of 7 people that filing names.
Linda Tussey is named as Executive Officer on the Form D that Terrestrial Bio, Inc. filed with the SEC on 19 March 2026, one of 7 people that filing names.
7 people named on the filing — 4 holding an executive role and 3 as directors only.
Named as of the 2026-03-19 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Terrestrial Bio, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Terrestrial Bio, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Terrestrial Bio, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Terrestrial Bio, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Terrestrial Bio, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Terrestrial Bio, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in Boston
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/terrestrial-bio-inc-form-d-26000001